Carlos Villalobos Selected Research

Carlos Villalobos Research Topics

Disease

11	Neoplasms (Cancer) 01/2021 - 09/2004
9	Alzheimer Disease (Alzheimer's Disease) 06/2023 - 07/2008
8	Colonic Neoplasms (Colon Cancer) 01/2019 - 02/2006
5	Colorectal Neoplasms (Colorectal Cancer) 03/2023 - 10/2014
3	Cognitive Dysfunction 01/2018 - 07/2008
2	Parkinson Disease (Parkinson's Disease) 06/2023 - 05/2012
2	Neurodegenerative Diseases (Neurodegenerative Disease) 12/2019 - 01/2010
1	Mitochondrial Diseases (Mitochondrial Disease) 06/2023
1	Nervous System Diseases (Neurological Disorders) 06/2023
1	Nerve Degeneration 05/2022
1	Tetraploidy 11/2021
1	Neuroinflammatory Diseases 01/2021
1	Infections 01/2020
1	Dementia (Dementias) 01/2018
1	Type 2 Diabetes Mellitus (MODY) 04/2017
1	Pituitary Neoplasms (Pituitary Adenoma) 01/2015
1	Hypopituitarism (Sheehan's Syndrome) 01/2015
1	Adenoma (Adenomas) 01/2015
1	Leukemia 05/2011
1	Inflammation (Inflammations) 01/2010
1	Carcinoma (Carcinomatosis) 11/2008

Drug/Important Bio-Agent (IBA)

9	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 01/2020 - 05/2011
8	CalciumIBA 06/2023 - 09/2004
5	Amyloid (Amyloid Fibrils)IBA 05/2022 - 01/2012
3	PolyaminesIBA 03/2023 - 01/2019
3	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2020 - 01/2016
2	Calcium Channels (Calcium Channel)IBA 01/2021 - 01/2020
2	Eflornithine (Ornidyl)FDA Link 01/2020 - 01/2019
2	SalicylatesIBA 06/2017 - 02/2006
2	NeurotoxinsIBA 01/2017 - 01/2016
2	Peptides (Polypeptides)IBA 01/2016 - 01/2012
2	Hormones (Hormone)IBA 01/2015 - 09/2004
2	AequorinIBA 01/2010 - 07/2008
1	Heterocyclic Compounds (Compounds, Heterocyclic)IBA 06/2023
1	AntioxidantsIBA 06/2023
1	Reactive Oxygen Species (Oxygen Radicals)IBA 06/2023
1	Reactive Nitrogen SpeciesIBA 06/2023
1	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 05/2022
1	NocodazoleIBA 11/2021
1	Cyclin-Dependent Kinases (cdk Proteins)IBA 11/2021
1	GalactosidasesIBA 11/2021
1	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2021
1	Adenosine Triphosphate (ATP)IBA 01/2021
1	A-factor (Streptomyces)IBA 01/2020
1	Sulindac (Copal)FDA LinkGeneric 01/2020
1	Toll-Like Receptor 4IBA 01/2020
1	Glutamate Receptors (Glutamate Receptor)IBA 01/2018
1	Messenger RNA (mRNA)IBA 04/2017
1	Anthocyanins (Anthocyanin)IBA 04/2017
1	Hypoglycemic Agents (Hypoglycemics)IBA 04/2017
1	Growth Hormone (Somatotropin)IBA 01/2015
1	Pituitary Hormone-Releasing HormonesIBA 01/2015
1	Stromal Interaction Molecule 2IBA 10/2014
1	Transient Receptor Potential ChannelsIBA 10/2014
1	Phosphotransferases (Kinase)IBA 05/2012
1	BuffersIBA 05/2011
1	Tetracycline (Achromycin)FDA LinkGeneric 01/2010
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2010
1	N-Methylaspartate (NMDA)IBA 01/2010
1	Minocycline (Cyclops)FDA LinkGeneric 01/2010
1	Transcription Factors (Transcription Factor)IBA 11/2008
1	1,25-dihydroxyvitamin DIBA 11/2008
1	Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA 11/2008
1	Calcitriol Receptors (Calcitriol Receptor)IBA 11/2008
1	Vitamin D FDA LinkGeneric 11/2008
1	amyloid beta-protein (1-42)IBA 07/2008
1	Amyloid beta-PeptidesIBA 07/2008
1	Pituitary Hormone-Regulating Hormone ReceptorsIBA 09/2004

Therapy/Procedure

3	Chemoprevention 01/2019 - 01/2016
1	Therapeutics 04/2017